Clinical Trial Update: Assessment of Pruritus Improvement With Pimecrolimus Treatment on the Areas Affected by Mild-to-moderate AD, in Patients 2- to 11- Year-old [Phase 4]

View source ↗

Summary

A completed Phase 4 clinical trial assessing whether pimecrolimus improves pruritus in children aged 2 to 11 with mild-to-moderate atopic dermatitis. Sponsored …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Elidel (pimecrolimus)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Atopic Dermatitis | Phase 4 | Status: COMPLETED